Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Pharmaceutical Policy and Practice|April 26, 2014
National medicines policies - a review of the evolution and development processesJoëlle M Hoebert, Liset van Dijk, Aukje K Mantel-Teeuwisse, et al.
Bulletin of the World Health Organization|June 16, 2011
Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countriesAlexandra Cameron, Ilse Roubos, Margaret Ewen, et al.
Pharmacoepidemiology and Drug Safety|February 26, 2011
Quality and completeness of utilisation data on biological agents across European countries: tumour necrosis factor alpha inhibitors as a case studyJoëlle M Hoebert, Aukje K Mantel-Teeuwisse, Liset van Dijk, et al.
The Lancet. Global Health|February 26, 2019
Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trialPeter C Rockers, Richard O Laing, Paul G Ashigbie, et al.
BMJ Global Health|August 20, 2019
Evaluation of pharmaceutical industry-led access programmes: a standardised frameworkPeter C Rockers, Richard O Laing, Nancy Scott, et al.
Health Policy and Planning|March 16, 2021
Phone-based monitoring to evaluate health policy and program implementation in KenyaPaul G Ashigbie, Peter C Rockers, Richard O Laing, et al.
BMC Health Services Research|May 4, 2021
Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in KenyaGloria Ng, Elizabeth Raskin, Veronika J Wirtz, et al.
BMJ Open|May 17, 2020
Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: a cross-sectional survey in eight countiesPaul G Ashigbie, Peter C Rockers, Richard O Laing, et al.
Pageof 2